Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?
Miller, Caela R, Chappell, Nicole P, Sledge, Caitlin, Leath, Charles A, Phippen, Neil T, Havrilesky, Laura J, Barnett, Jason C
Published in Gynecologic oncology (01.01.2017)
Published in Gynecologic oncology (01.01.2017)
Get full text
Journal Article